Clinical Trial Update: A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise [Phase 2]

View source ↗

Summary

Phase 2 study HTD1801 (berberine ursodeoxycholate) in adults with Type 2 Diabetes Mellitus completed. The trial was sponsored by HighTide Biopharma Pty Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HTD1801 (Berberine Ursodeoxycholate) (Berberine Ursodeoxycholate)

Snippet

Sponsor: HighTide Biopharma Pty Ltd | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED